These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
337 related articles for article (PubMed ID: 22252571)
1. Aberrant DNA methylation of tumor-related genes in oral rinse: a noninvasive method for detection of oral squamous cell carcinoma. Nagata S; Hamada T; Yamada N; Yokoyama S; Kitamoto S; Kanmura Y; Nomura M; Kamikawa Y; Yonezawa S; Sugihara K Cancer; 2012 Sep; 118(17):4298-308. PubMed ID: 22252571 [TBL] [Abstract][Full Text] [Related]
2. Detection of p16 promoter methylation in the serum of oral cancer patients. Nakahara Y; Shintani S; Mihara M; Hino S; Hamakawa H Int J Oral Maxillofac Surg; 2006 Apr; 35(4):362-5. PubMed ID: 16298513 [TBL] [Abstract][Full Text] [Related]
3. Gene hypermethylation in tumor tissue of advanced oral squamous cell carcinoma patients. Supić G; Kozomara R; Branković-Magić M; Jović N; Magić Z Oral Oncol; 2009 Dec; 45(12):1051-7. PubMed ID: 19665921 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinoma. Carvalho AL; Jeronimo C; Kim MM; Henrique R; Zhang Z; Hoque MO; Chang S; Brait M; Nayak CS; Jiang WW; Claybourne Q; Tokumaru Y; Lee J; Goldenberg D; Garrett-Mayer E; Goodman S; Moon CS; Koch W; Westra WH; Sidransky D; Califano JA Clin Cancer Res; 2008 Jan; 14(1):97-107. PubMed ID: 18172258 [TBL] [Abstract][Full Text] [Related]
5. Aberrant promoter hypermethylation in serum DNA from patients with silicosis. Umemura S; Fujimoto N; Hiraki A; Gemba K; Takigawa N; Fujiwara K; Fujii M; Umemura H; Satoh M; Tabata M; Ueoka H; Kiura K; Kishimoto T; Tanimoto M Carcinogenesis; 2008 Sep; 29(9):1845-9. PubMed ID: 18632757 [TBL] [Abstract][Full Text] [Related]
6. DNA methylation analysis by bisulfite next-generation sequencing for early detection of oral squamous cell carcinoma and high-grade squamous intraepithelial lesion from oral brushing. Morandi L; Gissi D; Tarsitano A; Asioli S; Monti V; Del Corso G; Marchetti C; Montebugnoli L; Foschini MP J Craniomaxillofac Surg; 2015 Oct; 43(8):1494-500. PubMed ID: 26302938 [TBL] [Abstract][Full Text] [Related]
7. Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Zöchbauer-Müller S; Fong KM; Virmani AK; Geradts J; Gazdar AF; Minna JD Cancer Res; 2001 Jan; 61(1):249-55. PubMed ID: 11196170 [TBL] [Abstract][Full Text] [Related]
8. Methylation array analysis of preoperative and postoperative saliva DNA in oral cancer patients. Viet CT; Schmidt BL Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3603-11. PubMed ID: 19064577 [TBL] [Abstract][Full Text] [Related]
9. Promotor hypermethylation of p14ARF is a key alteration for progression of oral squamous cell carcinoma. Ishida E; Nakamura M; Ikuta M; Shimada K; Matsuyoshi S; Kirita T; Konishi N Oral Oncol; 2005 Jul; 41(6):614-22. PubMed ID: 15975525 [TBL] [Abstract][Full Text] [Related]
10. p16(INK4a) promoter hypermethylation in oral scrapings of oral squamous cell carcinoma risk patients. Ruesga MT; Acha-Sagredo A; Rodríguez MJ; Aguirregaviria JI; Videgain J; Rodríguez C; de Pancorbo Mde L; Aguirre JM Cancer Lett; 2007 May; 250(1):140-5. PubMed ID: 17113222 [TBL] [Abstract][Full Text] [Related]
12. Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance. Lee ES; Issa JP; Roberts DB; Williams MD; Weber RS; Kies MS; El-Naggar AK Clin Cancer Res; 2008 May; 14(9):2664-72. PubMed ID: 18451230 [TBL] [Abstract][Full Text] [Related]
14. Salivary zinc finger protein 510 peptide as a novel biomarker for detection of oral squamous cell carcinoma in early stages. Jou YJ; Lin CD; Lai CH; Tang CH; Huang SH; Tsai MH; Chen SY; Kao JY; Lin CW Clin Chim Acta; 2011 Jul; 412(15-16):1357-65. PubMed ID: 21497587 [TBL] [Abstract][Full Text] [Related]
15. Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma. St John MA; Li Y; Zhou X; Denny P; Ho CM; Montemagno C; Shi W; Qi F; Wu B; Sinha U; Jordan R; Wolinsky L; Park NH; Liu H; Abemayor E; Wong DT Arch Otolaryngol Head Neck Surg; 2004 Aug; 130(8):929-35. PubMed ID: 15313862 [TBL] [Abstract][Full Text] [Related]
16. Serum circulating human mRNA profiling and its utility for oral cancer detection. Li Y; Elashoff D; Oh M; Sinha U; St John MA; Zhou X; Abemayor E; Wong DT J Clin Oncol; 2006 Apr; 24(11):1754-60. PubMed ID: 16505414 [TBL] [Abstract][Full Text] [Related]
17. Loss expression of O6-methylguanine DNA methyltransferase by promoter hypermethylation and its relationship to betel quid chewing in oral squamous cell carcinoma. Huang SH; Lee HS; Mar K; Ji DD; Huang MS; Hsia KT Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Jun; 109(6):883-9. PubMed ID: 20451846 [TBL] [Abstract][Full Text] [Related]
18. Aberrant promoter methylation in Chinese patients with non-small cell lung cancer: patterns in primary tumors and potential diagnostic application in bronchoalevolar lavage. Chan EC; Lam SY; Tsang KW; Lam B; Ho JC; Fu KH; Lam WK; Kwong YL Clin Cancer Res; 2002 Dec; 8(12):3741-6. PubMed ID: 12473584 [TBL] [Abstract][Full Text] [Related]
19. Interaction between the MTHFR C677T polymorphism and alcohol--impact on oral cancer risk and multiple DNA methylation of tumor-related genes. Supic G; Jovic N; Kozomara R; Zeljic K; Magic Z J Dent Res; 2011 Jan; 90(1):65-70. PubMed ID: 20940365 [TBL] [Abstract][Full Text] [Related]